FONR Stock Overview
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
FONAR Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$16.52 |
| 52 Week High | US$24.05 |
| 52 Week Low | US$12.13 |
| Beta | 1.13 |
| 1 Month Change | -23.55% |
| 3 Month Change | -14.14% |
| 1 Year Change | 2.61% |
| 3 Year Change | -7.45% |
| 5 Year Change | -18.01% |
| Change since IPO | -92.97% |
Recent News & Updates
Recent updates
FONAR Corporation (NASDAQ:FONR) Doing What It Can To Lift Shares
Apr 12
Fonar GAAP EPS of $1.75, revenue of $97.59M
Sep 27FONAR: Balance Sheet Trends Point To A Firm Bottom Shortly
Aug 31Adding To My Fonar Corporation Position
Jun 01The Returns On Capital At FONAR (NASDAQ:FONR) Don't Inspire Confidence
May 12Revisiting My FONAR Corp. Mistake
Feb 15FONAR Corporation: Finally Closing In On A Multi-Year Bottom
Oct 11FONAR (NASDAQ:FONR) May Have Issues Allocating Its Capital
May 10FONAR's (NASDAQ:FONR) Stock Price Has Reduced 19% In The Past Three Years
Mar 02Will FONAR (NASDAQ:FONR) Multiply In Value Going Forward?
Feb 09Is FONAR Corporation's (NASDAQ:FONR) Stock Price Struggling As A Result Of Its Mixed Financials?
Jan 19
What Kind Of Investors Own Most Of FONAR Corporation (NASDAQ:FONR)?
Dec 29Fonar reports Q1 results
Nov 12Shareholder Returns
| FONR | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -8.5% | -4.1% | -3.7% |
| 1Y | 2.6% | -2.2% | 20.5% |
Return vs Industry: FONR matched the US Medical Equipment industry which returned 2.2% over the past year.
Return vs Market: FONR underperformed the US Market which returned 20.2% over the past year.
Price Volatility
| FONR volatility | |
|---|---|
| FONR Average Weekly Movement | 5.0% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: FONR's share price has been volatile over the past 3 months.
Volatility Over Time: FONR's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1970 | 561 | Tim Damadian | www.fonar.com |
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down.
FONAR Corporation Fundamentals Summary
| FONR fundamental statistics | |
|---|---|
| Market cap | US$108.40m |
| Earnings (TTM) | US$12.36m |
| Revenue (TTM) | US$102.42m |
8.6x
P/E Ratio1.0x
P/S RatioIs FONR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FONR income statement (TTM) | |
|---|---|
| Revenue | US$102.42m |
| Cost of Revenue | US$55.65m |
| Gross Profit | US$46.77m |
| Other Expenses | US$34.41m |
| Earnings | US$12.36m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.91 |
| Gross Margin | 45.67% |
| Net Profit Margin | 12.07% |
| Debt/Equity Ratio | 0.09% |
How did FONR perform over the long term?
See historical performance and comparison